[Federal Register Volume 83, Number 157 (Tuesday, August 14, 2018)]
[Notices]
[Pages 40274-40275]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17439]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OARM-2018-0065; FRL-9981-87-OEI]


Information Collection Request Submitted to OMB for Review and 
Approval; Comment Request; Drug Testing for Contractor Employees 
(Renewal)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) has submitted an 
information collection request (ICR), Drug Testing for Contractor 
Employees (EPA ICR No. 2183.07, OMB Control No. 2030-0044), to the 
Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act. This is a proposed 
extension of the ICR, which is currently approved through August 31, 
2018. Public comments were previously requested via the Federal 
Register on May 11, 2018, during a 60-day comment period. This notice 
allows for an additional 30 days for public comments. A fuller 
description of the ICR is given below, including its estimated burden 
and cost to the public. An Agency may not conduct or sponsor and a 
person is not required to respond to a collection of information unless 
it displays a currently valid OMB control number.

DATES: Additional comments may be submitted on or before September 13, 
2018.

ADDRESSES: Submit your comments, referencing Docket ID Number EPA-HQ-
OARM-2018-0065, to (1) EPA online using www.regulations.gov (our 
preferred method), by email to

[[Page 40275]]

[email protected], or by mail to: EPA Docket Center, Environmental 
Protection Agency, Mail Code 28221T, 1200 Pennsylvania Ave. NW, 
Washington, DC 20460, and (2) OMB via email to 
[email protected]. Address comments to OMB Desk Officer for 
EPA.
    EPA's policy is that all comments received will be included in the 
public docket without change including any personal information 
provided, unless the comment includes profanity, threats, information 
claimed to be Confidential Business Information (CBI) or other 
information whose disclosure is restricted by statute.

FOR FURTHER INFORMATION CONTACT: Thomas Valentino, Policy, Training and 
Oversight Division, Office of Acquisition Management (3802R), 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460; telephone number: (202) 564-4522; email address: 
[email protected].

SUPPLEMENTARY INFORMATION: Supporting documents, which explain in 
detail the information that the EPA will be collecting, are available 
in the public docket for this ICR. The docket can be viewed online at 
www.regulations.gov or in person at the EPA Docket Center, WJC West, 
Room 3334, 1301 Constitution Ave. NW, Washington, DC. The telephone 
number for the Docket Center is 202-566-1744. For additional 
information about EPA's public docket, visit http://www.epa.gov/dockets.
    Abstract: This ICR applies to a contractor who performs response 
services at sensitive sites with serious security concerns where the 
Agency and public interest would best be protected through drug testing 
of contractor employees. The contractor will test employees for the use 
of marijuana, cocaine, opiates, amphetamines, phencyclidine (PCP), and 
any other controlled substances. Only contractor employees who have 
been tested within the previous 90 calendar days and have passing drug 
test results may be directly engaged in on-site response work and/or 
on-site related activities at designated sites with significant 
security concerns. The Agency may request contractors responding to any 
of these types of incidents to conduct drug testing and apply 
Government-established suitability criteria in Title 5 CFR 
Administrative Personnel 731.104 Appointments Subject to Investigation, 
732.201 Sensitivity Level Designations and Investigative Requirements, 
and 736.102 Notice to Investigative Sources, when determining whether 
employees are acceptable to perform on given sites or on specific 
projects.
    Form Numbers: None.
    Respondents/affected entities: Private Contractors.
    Respondent's obligation to respond: Required to obtain a benefit 
per Title 5 CFR Administrative Personnel 731.104 Appointments Subject 
to Investigation, 732.201 Sensitivity Level Designations and 
Investigative Requirements, and 736.102 Notice to Investigative 
Sources.
    Estimated number of respondents: 500 (total).
    Frequency of response: Annual.
    Total estimated burden: 1,125 hours (per year). Burden is defined 
at 5 CFR 1320.03(b).
    Total estimated cost: $129,100 (per year), includes $0 annualized 
capital or operation & maintenance costs.
    Changes in the Estimates: There is an increase of 112 hours in the 
total estimated respondent burden compared with the ICR currently 
approved by OMB. This increase is an adjustment due to more awarded 
contracts/orders performed on sensitive sites that require this drug 
testing for contractor employees.

Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2018-17439 Filed 8-13-18; 8:45 am]
 BILLING CODE 6560-50-P


